FGEN
FibroGen Inc
Price:  
1.12 
USD
Volume:  
991,664.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN Relative Valuation

-6558.5%
Upside

As of 2024-06-17, the Relative Valuation of FibroGen Inc (FGEN) is (72.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.12 USD, the upside of FibroGen Inc based on Relative Valuation is -6558.5%.

The range of the Relative Valuation is (71.55) - (72.52) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.6x - 30.9x 30.2x
Forward P/E multiples 29.2x - 30.0x 29.6x
Fair Price (71.55) - (72.52) (72.34)
Upside -6488.4% - -6574.7% -6558.5%
1.12 USD
Stock Price
(72.34) USD
Fair Price

FGEN Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 -0.46
2024-06-13 -0.48
2024-06-12 -0.48
2024-06-11 -0.47
2024-06-10 -0.47
2024-06-07 -0.46
2024-06-06 -0.49
2024-06-05 -0.50
2024-06-04 -0.49
2024-06-03 -0.51
2024-05-31 -0.50
2024-05-30 -0.48
2024-05-29 -0.48
2024-05-28 -0.53
2024-05-24 -0.54
2024-05-23 -0.53
2024-05-22 -0.51
2024-05-21 -0.49
2024-05-20 -0.50
2024-05-17 -0.50
2024-05-16 -0.51
2024-05-15 -0.49
2024-05-14 -0.49
2024-05-13 -0.50
2024-05-10 -0.48
2024-05-09 -0.50
2024-05-08 -0.47
2024-05-07 -0.57
2024-05-06 -0.48
2024-05-03 -0.47
2024-05-02 -0.47
2024-05-01 -0.48
2024-04-30 -0.46
2024-04-29 -0.45
2024-04-26 -0.43
2024-04-25 -0.42
2024-04-24 -0.41
2024-04-23 -0.44
2024-04-22 -0.47
2024-04-19 -0.48
2024-04-18 -0.48
2024-04-17 -0.53
2024-04-16 -0.54
2024-04-15 -0.54
2024-04-12 -0.54
2024-04-11 -0.56
2024-04-10 -0.59
2024-04-09 -0.62
2024-04-08 -0.67
2024-04-05 -0.67